Sensitizing of gemcitabine-resistant human leukemia cells by stearoyl gemcitabine nanoparticles

被引:0
|
作者
不详
机构
关键词
D O I
10.2217/NNM.11.146
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:1491 / 1492
页数:2
相关论文
共 50 条
  • [21] Establishment and characterization of three gemcitabine-resistant human intrahepatic cholangiocarcinoma cell lines
    Li, Jiandong
    Hu, Yanxin
    Zhang, Jiayao
    Zhang, Weiguang
    Yu, Jianhua
    Lu, Baochun
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [22] An exploratory study on the mechanism of pralatrexate killing gemcitabine-resistant pancreatic cancer cells
    Weng, W.
    Hong, J.
    Jiang, D.
    Chen, B.
    Zheng, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S431 - S431
  • [23] Options for the Treatment of Gemcitabine-Resistant Advanced Pancreatic Cancer
    Gounaris, Ioannis
    Zaki, Kamarul
    Corrie, Pippa
    JOURNAL OF THE PANCREAS, 2010, 11 (02): : 113 - 123
  • [24] Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway
    Zhou, Yunjiang
    Zhou, Yang
    Yang, Mengdi
    Wang, Keke
    Liu, Yisi
    Zhang, Mingda
    Yang, Yunjia
    Jin, Chenyu
    Wang, Rui
    Hu, Rong
    REDOX BIOLOGY, 2019, 22
  • [25] Ellagic Acid Resensitizes Gemcitabine-Resistant Bladder Cancer Cells by Inhibiting Epithelial-Mesenchymal Transition and Gemcitabine Transporters
    Wu, Ying-Si
    Ho, Jar-Yi
    Yu, Cheng-Ping
    Cho, Chun-Jung
    Wu, Chia-Lun
    Huang, Cheng-Shuo
    Gao, Hong-Wei
    Yu, Dah-Shyong
    CANCERS, 2021, 13 (09)
  • [26] Gemcitabine-resistant pancreatic ductal adenocarcinoma cells promote immunosuppressive tumor microenvironment
    Kajiwara, Yoshinori
    Tazawa, Hiroshi
    Nishiyama, Takeyoshi
    Shoji, Ryohei
    Fushimi, Takuro
    Kikuchi, Satoru
    Kuroda, Shinji
    Noma, Kazuhiro
    Yoshida, Ryuichi
    Nishizaki, Masahiko
    Kagawa, Shunsuke
    Fujiwara, Toshiyoshi
    CANCER SCIENCE, 2021, 112 : 560 - 560
  • [27] Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cells
    Che, Pei Pei
    Gregori, Alessandro
    Bergonzini, Cecilia
    Ali, Mahsoem
    Mantini, Giulia
    Schmidt, Thomas
    Finamore, Francesco
    Rodrigues, Stephanie M. Fraga
    Frampton, Adam E.
    McDonnell, Liam A.
    Danen, Erik H.
    Slotman, Ben J.
    Sminia, Peter
    Giovannetti, Elisa
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : 1328 - 1343
  • [28] SUMOylation plays a role in gemcitabine- and bortezomib-induced cytotoxicity in human oropharyngeal carcinoma KB gemcitabine-resistant clone
    Chung, V
    Zhou, B
    Liu, XY
    Zhu, L
    Boo, LM
    Nguyen, HV
    Ann, DK
    Song, J
    Chen, Y
    Yen, Y
    MOLECULAR CANCER THERAPEUTICS, 2006, 5 (03) : 533 - 540
  • [29] Identifying microRNA-mRNA regulatory network in gemcitabine-resistant cells derived from human pancreatic cancer cells
    Shen, Yehua
    Pan, Yan
    Xu, Litao
    Chen, Lianyu
    Liu, Luming
    Chen, Hao
    Chen, Zhen
    Meng, Zhiqiang
    TUMOR BIOLOGY, 2015, 36 (06) : 4525 - 4534
  • [30] Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma
    Borsoi, Carlotta
    Leonard, Fransisca
    Lee, Yeonju
    Zaid, Mohamed
    Elganainy, Dalia
    Alexander, Jenolyn Francisca
    Kai, Megumi
    Liu, Yan Ting
    Kang, Yaan
    Liu, Xuewu
    Koay, Eugene J.
    Ferrari, Mauro
    Godin, Biana
    Yokoi, Kenji
    CANCER LETTERS, 2017, 403 : 296 - 304